Voluntary Recall of One Lot of Gardasil HPV Vaccine (2013)
- Why was there a recall of the Gardasil HPV vaccine?
- If my child received one of the affected HPV vaccine vial injections, what could happen?
- If my child received the HPV vaccine injection from this affected lot, does he or she have to be vaccinated again?
- How will I know if my child received one of the affected HPV vaccinations?
On December 16, 2013 CDC was informed by Merck that the company planned to implement a voluntary recall of one lot (lot J007354) of Gardasil [Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine, Recombinant], due to the potential for a small number of vials to contain glass particles as a result of breakage during the manufacturing process. These vials were distributed between August 20, 2013, and October 9, 2013. No other lots were affected.
If a vaccine containing glass particles (tiny enough to get through a needle) is given to a patient, mild reactions routinely seen after vaccination may occur (for instance, redness or swelling at the injection site). There are multiple safety systems in this country that track and monitor vaccine safety, including the Vaccine Adverse Event Reporting System (VAERS), which allows anyone to report a possible vaccine side effect (also called “adverse event”). To date, no adverse events related to this lot of HPV vaccine have been reported other than mild reactions such as redness and swelling at the injection site. It is not expected that delayed side effects will occur.
If my child received the HPV vaccine injection from this affected lot, does he or she have to be vaccinated again?
If your child received HPV vaccination from this one affected lot, he or she does NOT have to be vaccinated again. The vaccine’s effectiveness is not impacted by this problem. The HPV vaccine series is given in 3 shots over 6 months. Be sure that your child gets all 3 shots for full protection.
Merck is currently contacting its direct customers (doctors’ offices or clinics) who have purchased or received product from the affected lot. People who have recently received an HPV vaccine, including those who received vaccine from the affected lot, do not need to take any action as a result of this recall. Because no action is necessary, CDC is not asking doctors to notify patients who have received vaccine from the affected lot. However, if you want to know if your child received a dose of vaccine from the affected lot, you can ask his or her doctor.
For questions about this recall or to report any adverse events following vaccination, please contact: Merck National Service Center at 800-444-2080.
Yes. This recall was caused by an isolated problem in the vaccine manufacturing process. HPV vaccine continues to have a strong safety record, and CDC continues to recommend that all preteen girls and boys receive three doses of this cancer-preventing vaccine at age 11 or 12 years. To learn more about HPV vaccine and the diseases it prevents, visit CDC’s HPV Information Portal.